arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Inspire Medical Systems, Inc.

INSP
$69.04 ▼ -2.21 (-3.10%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
40 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
75
Health
Good
Bullish
auto_awesome

Analytical Summary

Inspire Medical Systems, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $2.0B
Dividend Yield —
Revenue Growth -7.6% ↘
Op. Margin -0.3% ↗
ROIC -0.0% ↘
FCF / Share $0.49 ↗
Trailing P/E 6904.0x
Price / Book 2.4x
FCF Yield 0.7%
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

40-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$200.58M
↓ -7.6% —
Net Income Profit after all expenses
$-11.29M
— 0.0% —
Operating Margin Operating profit as % of sales
-0.3%
↑ +53.1% 44th
FCF / Share Free cash flow per share
$0.49
↑ +348.4% —
Long-Term Debt Long-term obligations
$21.40M
↓ -12.7% —
trending_up

Bullish Indicators

  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
59
Returns
85
Financial Health
97
Cash Quality ↓
42

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 10 years · 40 quarters